European committee takes a second look at Alzheimer's drug and now says it should be approved
A European regulatory committee now recommends approval of the Alzheimer's treatment lecanemab a few months after rejecting ...
Verywell Health on MSN33m
Zepbound Cuts the Risk of Progressing to Diabetes by 94%, Eli Lilly Data Shows
Eli Lilly's tirzepatide cut the risk of developing type 2 diabetes for people with pre-diabetes by 94%, according to new ...
FOX 5 Atlanta47m
New FDA rules target those ubiquitous TV drug commercials
The agency’s new guidelines are created to eliminate pharmaceutical company practices that minimize or distract consumers ...